Wed, Aug 14, 8:44 PM (153 days ago)
On August 14, 2024, CONMED Corporation announced the termination of Stanley W. (Bill) Peters, President of Advanced Surgical & Advanced Endoscopic Technologies, effective August 31, 2024. His departure will trigger compensation and benefits as per the Executive Severance Plan outlined in the company's Proxy Statement filed on April 8, 2024. This leadership change may impact the company’s strategic direction and operational focus in its advanced surgical technologies segment. As CONMED navigates this transition, stakeholders should monitor its future performance and potential implications for stock value. The company, listed under the ticker CNMD on the NYSE, is classified as an emerging growth company.